Jade Biosciences, Inc. (NASDAQ:JBIO – Get Free Report)’s stock price was down 4.2% during trading on Monday . Two investment analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Get Jade Biosciences alerts:Get Our Latest Stock Analysis on JBIOJade Biosciences Price PerformanceThe company has a market cap of $933.89 million, a P/E ratio of -9.34 and a beta of 1.49. Jade Biosciences (NASDAQ:JBIO – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. Read MoreReceive News & Ratings for Jade Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jade Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.